SCHEMBL2462745

SCHEMBL2462745

CN(C)C(CC(N)=O)C1(C(=O)O)CCC(C2=C3C=NC=C[N+]3(N)C(c3cccc(OCc4ccccc4)c3)=N2)CC1

nearest known ligand 0.34

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 8/20 0.34
ADAM17 P78536 1/20 0.32
KCNH2 Q12809 1/20 0.32
MAOB P27338 1/20 0.32
BTK Q06187 1/20 0.32
TNK2 Q07912 1/20 0.32
CTSA P10619 1/20 0.32
F10 P00742 2/20 0.32
F9 P00740 1/20 0.32
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
JAK2 O60674 1/20 0.32
JAK1 P23458 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2457720 0.88 IGF1R (0.34) IGF1RADAM17KCNH2MAOBBTK
SCHEMBL2457743 0.87 KDM4E (0.34) IGF1RKCNH2MAOBBTKTNK2
SCHEMBL2460164 0.85 ACACB (0.35) IGF1RADAM17MAOBF10KMT2A
SCHEMBL2457738 0.85 SPHK1 (0.37) IGF1RBTKF10F9
SCHEMBL5115303 0.84 IGF1R (0.35) IGF1RADAM17KCNH2BTKF10
SCHEMBL5109184 0.84 IGF1R (0.34) IGF1RADAM17KCNH2BTKF10
SCHEMBL2457199 0.83 IGF1R (0.34) IGF1RADAM17KCNH2BTKF10
SCHEMBL2460657 0.83 ADAM17 (0.39) IGF1RADAM17KCNH2BTKF10
SCHEMBL2461705 0.82 KCNH2 (0.32) IGF1RKCNH2BTKF10F9
SCHEMBL2460551 0.82 IGF1R (0.48) IGF1RKCNH2BTKF10JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1675860-B1 IMIDAZO[1,5-A]PYRAZINES AS TYROSINE KINASE INHIBITORS OSI PHARM INC (US) 2011-09-21 EP claimed
EP-1675860-B1 IMIDAZO[1,5-A]PYRAZINES AS TYROSINE KINASE INHIBITORS OSI PHARM INC (US) 2011-09-21 EP disclosed
US-7459554-B2 Imidazopyrazine tyrosine kinase inhibitors OSI PHARMACEUTICALS, INC. (US) 2008-12-02 US disclosed